Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Gypenosides for Acute Optic Neuritis
NCT02976766Phase 2Terminated
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Feb 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in optic neuritis (ON) comparing Gypenosides with Placebo (2 arms). Primary endpoint: Mean peripapillary retinal nerve fiber layer thickness at 6 months. Started Feb 2017; status: terminated.
02
Drugs
gypenosides
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT02976766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02976766.